Mark
Booth
Chief Commercialization Office, Orexigen Therapeutics, Inc.
Richard
Brewer
President and CEO, Arca Discovery Inc.
G.
Steven Burrill
CEO, President and Chairman, Burrill
& Co.
Chris
Ehrlich
Venture Partner, Interwest
Partners
David
Flores
President and CEO, BioCentury
Paul
Fonteyne
Executive Vice President, Boehringer
Ingelheim
Marc-Henri
Galletti
Managing Director, Longitude Capital
Winton
Gibbons
SVP, Business Development, Nanosphere
Inc.
Misty
Gruber
Attorney, Dykema Gossett PLLC
Arthur
Holden
Chairman, Pharmaceutical Biomedical Research Consortium, Ltd.
Barry
Labinger
COO, Human Genome Sciences,
Inc.
John Larson
General Manager, Global Alliance mgmt, Abbott Labs
Bruno
Larvol
President and CEO, The Larvol Group, Inc.
Scott
Minick
Partner, ARCH
Venture Partners
Arthur Pancoe
Senior Managing Director, Morgan Stanley & Co.
H.
Stewart Parker
CEO, Targeted
Genetics
Norbert
Riedel
Corp. Vice President & CSO, Baxter
Healthcare Corp.
Spiro
Rombotis
CEO, Cyclacel
Pharmaceuticals Limited
Lydia
Villa-Komaroff
CEO, Cytonome, Inc.
Michael Webb
President & CEO, Allegro Diagnostics
